Intraamniotic Inflammation in Women with Preterm Prelabor Rupture of Membranes

PLoS One. 2015 Jul 24;10(7):e0133929. doi: 10.1371/journal.pone.0133929. eCollection 2015.

Abstract

Objective: To characterize subgroups of preterm prelabor rupture of membranes (PPROM) and short-term neonatal outcomes based on the presence and absence of intraamniotic inflammation (IAI) and/or microbial invasion of the amniotic cavity (MIAC).

Methods: One hundred and sixty-six Caucasian women with singleton pregnancies were included in this study. Amniotic fluid samples were obtained by transabdominal amniocentesis (n=166) and were assayed for interleukin-6 levels by a lateral flow immunoassay. The presence of Ureaplasma species, Mycoplasma hominis, Chlamydia trachomatis, and 16S rRNA was evaluated in the amniotic fluid. IAI was defined as amniotic fluid IL-6 values, measured by a point of care test, higher than 745 pg/mL.

Results: Microbial-associated IAI (IAI with MIAC) and sterile intraamniotic inflammation (IAI alone) were found in 21% and 4%, respectively, of women with PPROM. Women with microbial-associated IAI had higher microbial loads of Ureaplasma species in the amniotic fluid than women with MIAC alone. No differences in the short-term neonatal morbidity with respect to the presence of microbial-associated IAI, sterile IAI and MIAC alone were found after adjusting for the gestational age at delivery in women with PPROM.

Conclusions: Microbial-associated but not sterile intraamniotic inflammation is common in Caucasian women with PPROM. The gestational age at delivery but not the presence of inflammation affects the short-term neonatal morbidity of newborns from PPROM pregnancies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amniotic Fluid / metabolism
  • Amniotic Fluid / microbiology
  • Chorioamnionitis / epidemiology
  • Chorioamnionitis / etiology*
  • Chorioamnionitis / microbiology
  • Female
  • Fetal Membranes, Premature Rupture*
  • Humans
  • Infant, Newborn
  • Interleukin-6 / metabolism
  • Pregnancy
  • Prevalence
  • RNA, Ribosomal, 16S

Substances

  • Interleukin-6
  • RNA, Ribosomal, 16S

Grants and funding

This work was supported by 1) a grant from the Ministry of Health of the Czech Republic (NS 13461-4/2012), and 2) Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project “PRVOUK” P37/10.